Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. (Q40209862)
Jump to navigation
Jump to search
scientific article published on 15 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. |
scientific article published on 15 December 2011 |
Statements
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells (English)
F Rothweiler
S Barth
J Cinatl
M van Rikxoort
N Löschmann
Y Voges
F Rödel
K Weber
E Mack
H W Doerr
D Speidel
15 December 2011